XML 49 R39.htm IDEA: XBRL DOCUMENT v3.24.3
Fair Value of Assets and Liabilities - Assets and Liabilities (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
USD ($)
property
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
property
Sep. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis          
Impairment of assets | $ $ 23,031 $ 1,156 $ 41,718 $ 18,380  
Number of Properties | property 368   368    
Held for sale          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis          
Number of Properties | property 25   25    
Life Sciences Property          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis          
Impairment of assets | $ $ 23,031        
Corporate Joint Venture          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis          
Number of Properties | property 11   11    
Corporate Joint Venture | Seaport Innovation LLC          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis          
Equity method investment ownership percentage 10.00%   10.00%    
Holding period     10 years    
Number of Properties | property 1   1    
Corporate Joint Venture | Seaport Innovation LLC | Discount Rate          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis          
Measurement input 0.0750   0.0750    
Corporate Joint Venture | Seaport Innovation LLC | Exit Capitalization Rate          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis          
Measurement input 0.0600   0.0600    
Corporate Joint Venture | The LSMD Fund REIT LLC          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis          
Equity method investment ownership percentage 20.00%   20.00%    
Number of Properties | property 10   10    
Corporate Joint Venture | The LSMD Fund REIT LLC | Minimum          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis          
Holding period     10 years    
Corporate Joint Venture | The LSMD Fund REIT LLC | Maximum          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis          
Holding period     13 years    
Corporate Joint Venture | The LSMD Fund REIT LLC | Discount Rate | Minimum          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis          
Measurement input 0.0650   0.0650    
Corporate Joint Venture | The LSMD Fund REIT LLC | Discount Rate | Maximum          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis          
Measurement input 0.0800   0.0800    
Corporate Joint Venture | The LSMD Fund REIT LLC | Exit Capitalization Rate | Minimum          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis          
Measurement input 0.0525   0.0525    
Corporate Joint Venture | The LSMD Fund REIT LLC | Exit Capitalization Rate | Maximum          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis          
Measurement input 0.0700   0.0700    
Corporate Joint Venture | The LSMD Fund REIT LLC | Direct Capitalization Rate          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis          
Measurement input 0.0500   0.0500    
Recurring Fair Value Measurements Assets | Level 3 | Joint Venture | Carrying Value | Seaport Innovation LLC          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis          
Investments in affiliates, fair value | $ $ 65,590   $ 65,590   $ 85,699
Recurring Fair Value Measurements Assets | Level 3 | Joint Venture | Carrying Value | The LSMD Fund REIT LLC          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis          
Investments in affiliates, fair value | $ 44,923   44,923   44,217
Non-Recurring Fair Value Measurements Assets | Life Sciences Property          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis          
Aggregate sales price | $ $ 6,286   $ 6,286    
Non-Recurring Fair Value Measurements Assets | Life Sciences Property | Held for sale          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis          
Number of Properties | property 1   1    
Non-Recurring Fair Value Measurements Assets | Level 2 | Carrying Value          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis          
Real estate properties held for sale | $ $ 6,286   $ 6,286   $ 0